iBio, Inc. Business Finance Contracts & Agreements
57 Contracts & Agreements
- Credit Agreements (5 contracts)
- Equity Distribution Agreements (2)
- Exchange Agreements (1)
- Guaranty Agreements (1)
- Investor Rights Agreements (1)
- Note Agreements (2)
- Purchase Agreements (8)
- Registration Rights Agreements (5)
- Security Agreements (2)
- Share Agreements (3)
- Stock Agreements (6)
- Underwriting Agreements (11)
- Warrant Agreements (10)
- Purchase and Sale Agreement, dated September 15, 2023, by and between iBio CDMO LLC and Majestic Realty Co (Filed With SEC on September 21, 2023)
- Sixth Amendment, dated September 18, 2023, to the Credit Agreement by and between iBio CDMO LLC and Woodforest National Bank (Filed With SEC on September 21, 2023)
- Purchase Agreement, dated as of August 4 2023, by and between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 4, 2023)
- Registration Rights Agreement, dated as of August4, 2023, by and between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 4, 2023)
- Third Amendment to Credit Agreement dated February 21, 2023 between iBio CDMO LLC and Woodforest National Bank and Third Amended Guaranty of iBio, Inc (Filed With SEC on February 21, 2023)
- Second Amendment to Credit Agreement dated February 9, 2023 by and between iBio, Inc. and Woodforest National Bank (Filed With SEC on February 14, 2023)
- Underwriting Agreement, dated December 6, 2022, by and between iBio, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 8, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on December 8, 2022)
- Restricted Stock Unit Award Agreement dated November 10, 2022 by and between iBio, Inc. and Thomas Isett (Filed With SEC on November 14, 2022)
- First Amendment to Credit Agreement entered into as of October 11, 2022 by and between iBio CDMO LLC with Woodforest National Ban (Filed With SEC on October 11, 2022)
- Asset Purchase Agreement, dated September 16, 2022, by and between iBio, Inc. and Rubryc Therapeutics, Inc (Filed With SEC on September 21, 2022)
- Form of Stock Purchase Agreement (Filed With SEC on May 12, 2022)
- Term Note of iBio CDMO LLC (Filed With SEC on November 4, 2021)
- iBio, Inc. Warrant (Filed With SEC on November 4, 2021)
- Purchase and Sale Agreement, dated November 1, 2021, by and among College Station Investors LLC, Bryan Capital Investors LLC, iBio CDMO LLC and iBio, Inc (Filed With SEC on November 4, 2021)
- Equity Purchase Agreement dated November 1, 2021 by and between Bryan Capital Investors LLC and iBio, Inc (Filed With SEC on November 4, 2021)
- Credit Agreement, dated November 1, 2021 by and, between iBio CDMO LLC with Woodforest National Bank (Filed With SEC on November 4, 2021)
- Guaranty Agreement, dated November 1, 2021, by iBio, Inc. for the benefit of Woodforest National Bank (Filed With SEC on November 4, 2021)
- Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and UCC Financing Statement for Fixture Filing by iBio CDMO LLC as grantor to the trustee for the... (Filed With SEC on November 4, 2021)
- Security Agreement, dated November 1, 2021by iBio CDMO LLC for the benefit of Woodforest National Bank (Filed With SEC on November 4, 2021)
- Stock Purchase Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)
- Second Amended and Restated Investor Rights Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)
- Underwriting Agreement, dated December 8, 2020, between iBio, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 9, 2020)
- Amendment No. 1 to Equity Distribution Agreement, dated July 29, 2020, by and between iBio, Inc. and UBS Securities LLC (Filed With SEC on July 29, 2020)
- Form of Stock Option Agreement (Filed With SEC on June 17, 2020)
- Equity Distribution Agreement, dated June 17 2020, by and between iBio, Inc. and UBS Securities, LLC (Filed With SEC on June 17, 2020)
- Purchase Agreement, dated as of May 13, 2020, between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2020)
- Registration Rights Agreement, dated March 19, 2020, between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on March 20, 2020)
- Purchase Agreement, dated March 19, 2020, between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on March 20, 2020)
- Form of Amended and Restated Series A Warrant to Purchase Common Stock (Filed With SEC on February 21, 2020)
- Form of Amended and Restated Series B Warrant to Purchase Common Stock (Filed With SEC on February 21, 2020)
- Form of Promissory Note (Filed With SEC on February 21, 2020)
- Warrant Exchange and Amendment Agreement, between the Company and certain Holders, dated February 20, 2020 (Filed With SEC on February 21, 2020)
- Underwriting Agreement, dated October 25, 2019, by and between iBio, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on October 29, 2019)
- Underwriting Agreement, dated October 25, 2019, by and between iBio, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on October 28, 2019)
- Form of Series A Warrant to Purchase Common Stock (Filed With SEC on October 28, 2019)
- Form of Series B Warrant to Purchase Common Stock (Filed With SEC on October 28, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 24, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 15, 2019)
- Form of Series A Warrant to Purchase Common Stock (Filed With SEC on October 15, 2019)
